Summit Tx Capital, L.P. Axsome Therapeutics, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 2,709 shares of AXSM stock, worth $325,892. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,709Holding current value
$325,892% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.3MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$475 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$397 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$203 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$182 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$137 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.16B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...